Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses [NA]
The clinical trial evaluating a simple ultrasound-based rule diagnostic tool for adnexal masses has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients [NA]
The University of Michigan completed a clinical trial evaluating guided imagery as a perioperative intervention in gynecologic oncology pati…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission [Phase 1]
A Phase 1 study of a unimolecular pentavalent immunization (Globo-H-GM2-sTn-TF-Tn) in patients with epithelial ovarian cancer, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer [Phase 1]
Phase 1 trial evaluating [18F]Fluciclatide-PET in combination with Pazopanib and Paclitaxel for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse Caregivers [NA]
A completed clinical trial evaluating the Taking Care of Her caregiver support program for patients with Stage III/IV ovarian cancer and the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer [Phase 2]
Phase 2 efficacy trial of recombinant interleukin-21 for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: OSCA - Olaparib Standard of CAre Study
The OSCA trial evaluating olaparib as standard of care in platinum-sensitive recurrent serous ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer [Phase 2]
Phase 2 trial update on allogeneic natural killer (NK) cells for ovarian, fallopian tube, peritoneal, and metastatic breast cancer; study co…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Phase 3]
This is a Phase 3 clinical trial evaluating whether intravenous glutathione can prevent paclitaxel/carboplatin-induced peripheral neuropathy…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating STM-434 alone or with liposomal doxorubicin in ovarian cancer, fallopian tube cancer, endometrial cancer, and other…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study of topotecan in combination with carboplatin for relapsed ovarian cancer, …
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: BRCA1 and BRCA2 Mutation in Romanian Population: a Study of Genotype - Phenotype Correlation at Diagnosis With Prospective Disease Outcome and Survival
A completed study assessing the prevalence and penetrance of BRCA1 and BRCA2 mutations in Romanian women with breast or ovarian cancer, and …
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: High-dose ICE With Amifostine [Phase 2]
Phase 2 trial evaluating high-dose ICE chemotherapy with Amifostine has completed accrual and results are reported for multiple solid tumors…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer [Phase 2]
The update reports completion of a Phase 2 trial evaluating the safety and effects of EMD 72000 in subjects with recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of lenalidomide with doxorubicin liposome in recurrent ovarian, fallopian tube, or primary peritoneal cancer; the s…
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer [Phase 1]
A Phase 1 study of DMOT4039A in participants with unresectable pancreatic cancer or platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Internet-based System for Cancer Patients to Self-report Toxicity [NA]
This updates on a completed clinical trial evaluating an internet-based system that allows cancer patients to self-report treatment-related …
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy plus peripheral stem cell transplantation for relapsed germ cell cancer; results have been…
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: How Our Immune System Can Help Fight Cancer
The update describes how immune-based strategies are being explored to help treat cancer. It notes that the associated clinical trial (NCT01…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
Phase 2 trial of Hu3S193 as consolidation therapy for women with ovarian, fallopian tube, or primary peritoneal cancer; the study is termina…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
A phase 2 trial evaluated docetaxel with or without vandetanib in patients with persistent or recurrent ovarian epithelial cancer, fallopian…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer [Phase 2]
A Phase 2 study evaluating first-line intraperitoneal cisplatin and etoposide for bulky stage IIIC/IV epithelial ovarian cancer and related …
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer [Phase 3]
This update reports the completion of the TRINOVA-1 Phase 3 trial evaluating AMG 386 in combination with weekly paclitaxel for fallopian tub…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors [Phase 2]
Phase 2 trial update on belinostat for advanced ovarian epithelial cancer, primary peritoneal cancer, fallopian tube cancer, and ovarian low…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125 [Phase 1, Phase 2]
Clinical trial update for E7080 (lenvatinib) in combination with carboplatin and gemcitabine versus carboplatin and gemcitabine alone as sec…